This Stock Will Go Ex-Dividend For Rs 377 Per Share Dividend On April 28

Pharma major Sanofi will go ex-dividend for a dividend of Rs 377 per share on April 28, 2023. The company declared a solid final dividend of Rs 194 per share and a special dividend of Rs 183 per share, the book closure of which will be April 28, 2023.

52-week high and low of Sanofi India

The stock of Sanofi India last traded at Rs 5959.90 on the Bombay Stock Exchange. The shares of the company have hit a 52-week high of Rs 7227.70 and has dropped to a 52-week low of Rs 5240. The stock is now available with a solid dividend of Rs 377 per share. According to the Bombay Stock Exchange data, the trailing p/e of the stock is around 22 times.

Sanofi India: A top pharma player

Sanofi India is one of the top players in the pharma business and has a very consistent track record of declaring dividends.

The company has prioritised diabetes management as a core area of focus. By bringing its comprehensive range of diabetes management solutions (orals and injectables) and complementing it with education about the disease, its causes, and preventive measures, Sanofi India is making significant progress in addressing this health issue.

The company is also equally committed to the other areas of therapy that it has expertise in. Sanofi India has large-scale manufacturing presence with a site in Goa and 12 Contract Manufacturing Organisations (CMOs) in different parts of India.

It produces pharmaceutical formulations, dosage forms and offer an extensive range of innovative medicines across vital therapeutic areas. The brands of the company are leaders in their respective categories and are a testament to our long history of superior quality, consistent supply, and demonstrated scientific competence.

Disclaimer

The above-mentioned information is purely informational and highlights the good dividend of the stock. Stock investments are subject to market risks. The article should be treated as informational and not an advisory to invest. Greynium Information Technologies and the Author are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before making any investment decision.